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Abstract—Two cathepsin B inhibitors were isolated from the culture supernatant of a marine Pseudomonas sp. PB01 (GenBank
Accession No. EU126129). Their structures were elucidated by spectroscopic analyses as dibutyl phthalate and di-(2-ethylhexyl)
phthalate. Both dibutyl phthalate and di-(2-ethylhexyl) phthalate showed dose-dependent cathepsin B inhibitions with IC50 of
0.42 and 0.38 mM, respectively. It is also observed from kinetic analyses that dibutyl phthalate and di-(2-ethylhexyl) phthalate acted
as noncompetitive inhibitors with Ki values of 0.64 and 0.42 mM, respectively. Furthermore, both of them caused inactivation of the
pericellular cathepsin B of murine melanoma cell with no acute cytotoxicity. The IC50 values were found to be 0.23 mM for dibutyl
phthalate and 0.14 mM for di-(2-ethylhexyl) phthalate, respectively, and were 50% compared to that of purified cathepsin B.
 2008 Elsevier Ltd. All rights reserved.
The lysosomal cysteine proteases cathepsin B (EC
3.4.22.1) is a unique cysteine member showing dual
roles as both endopeptidase and exopeptidase activi-
ties, due to the presence of the occluding loop in
structure.1 In normal conditions, cathepsin B plays a
role in intracellular protein catabolism; and is also in-
volved in hormone activation and processing of anti-
gens in immune response. Over-expression and
mislocation in cell membrane of cathepsin B, however,
have contributed to several pathological processes that
include cancer and neurogenerative disorders.2–4
Cathepsin B inhibitors have been reported to cause
changes in malignant tumors.5 The inhibition of
cathepsin B has also been proved to decrease the
severity of joint inflammation and to reduce the
destruction of particular tissues in the rat model of
antigen adjuvant-induced arthritis. Cathepsin B inhib-
itors are therefore expected to be useful for the treat-
ment of inflammatory joint disease, invasion of
cancer, and other diseases related to cathepsin B
disorder.
Inhibitors of cathepsin B include endogenous inhibi-
tors such as the cystatin superfamily, low molecular
weight natural, and chemical synthesis inhibitors, that
is, leupeptin, E-64, tokaramide A, CA030, and
CA074.6. Marine organisms, including microorganisms
represent as treasure sources for therapeutic natural
products. To explore new cathepsin B inhibitors, cul-
ture broths from more than 300 marine microorgan-
isms were investigated by enzyme inhibitory assay.
The most interesting microorganism Pseudomonas sp.
PB01 (GenBank Accession No. EU126129) was cho-
sen. In this study, we described the isolation, structure
elucidation, and enzyme inhibitory activities of pure
compounds from culture broth of strain PB01. More-
over, pericellular cathepsin B inhibition was studied in
order to assess in vivo potential of the isolated
compounds.
Cathepsin B and 3-(4,5-dimethylthiazol-2-yl)-2,5-diph-
enyltetrazoliumbromide (MTT) were purchased from
Sigma Chemical Co. (St. Louis, MO). Z-Arg-Arg-
MCA was purchased from Bachem AG (Switzer-
land). Murine melanoma cell, B16F10 (ATCC
CRL-6475) was obtained from American Type of
Culture Collection (Manassas, VA, USA). Cell cul-
ture medium and all the other materials required
for culturing were obtained from Gibco (Grand Is-
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